Results 81 to 90 of about 6,798 (212)

Recombinant anti-monkey CD3 immunotoxin depletes peripheral lymph node T lymphocytes more effectively than rabbit anti-thymocyte globulin in naive baboons

open access: yes, 2013
T cell depletion is an important procedure for both experimental and therapeutic immune modulation. Rabbit anti-thymocyte globulin (ATG), which is a commonly used T cell depletion antibody in clinical organ and cell transplantation protocols, is ...

core   +1 more source

Immunotoxins and Anticancer Drug Conjugate Assemblies: The Role of the Linkage between Components

open access: yesToxins, 2011
Immunotoxins and antibody-drug conjugates are protein-based drugs combining a target-specific binding domain with a cytotoxic domain. Such compounds are potentially therapeutic against diseases including cancer, and several clinical trials have shown ...
Luigi Cattel, Paola Brusa, Franco Dosio
doaj   +1 more source

Site-Specific PEGylation of Recombinant Immunotoxin DAB389IL-2: Structural and Functional Assessment

open access: yesResearch in Molecular Medicine, 2019
Background: DAB389IL-2 is considered a fusion immunotoxin and it is used for the CTCL therapy. DAB389IL-2 includes of two distinct portions; the catalytic domain of diphtheria toxin and IL-2. DAB389IL-2 duo to the presence of a free cysteine residue (Cys
Nasrin Zarkar   +5 more
doaj  

Targeted Toxins in Brain Tumor Therapy

open access: yesToxins, 2010
Targeted toxins, also known as immunotoxins or cytotoxins, are recombinant molecules that specifically bind to cell surface receptors that are overexpressed in cancer and the toxin component kills the cell.
Walter A. Hall, Yan Michael Li
doaj   +1 more source

A novel bispecific immunotoxin delivered by human bone marrow-derived mesenchymal stem cells to target blood vessels and vasculogenic mimicry of malignant gliomas

open access: yes, 2015
Yonghong Zhang,1,2 Xinlin Sun,1 Min Huang,1 Yiquan Ke,1 Jihui Wang,1 Xiao Liu1 1National Key Clinic Specialty, Neurosurgery Institute of Guangdong Province, Guangdong Provincial Key Laboratory on Brain Function Repair and Regeneration, Department of ...
Ke Y   +5 more
core  

Enhancing immunotoxin cell-killing activity via combination therapy with ABT-737.

open access: yes, 2011
Immunotoxins are antibody-toxin fusion proteins directed to kill cancer cells displaying specific target antigens on their surface. Remarkably, immunotoxins directed to CD22 on hairy cell leukemia have produced complete remissions in approximately 60% of
Wayne, Alan   +21 more
core   +1 more source

Targeted Diphtheria Toxin-Based Therapy: A Review Article

open access: yesFrontiers in Microbiology, 2019
Cancer remains one of the leading causes of death worldwide. Conventional therapeutic strategies usually offer limited specificity, resulting in severe side effects and toxicity to normal tissues.
Fatemeh Shafiee   +2 more
doaj   +1 more source

Efficient in vivo antitumor effect of an immunotoxin based on ribotoxin α-sarcin in nude mice bearing human colorectal cancer xenografts [PDF]

open access: yes, 2015
Tagging of RNases, such as the ribotoxin α-sarcin, with the variable domains of antibodies directed to surface antigens that are selectively expressed on tumor cells endows cellular specificity to their cytotoxic action.
Olombrada Sacristán, Miriam   +28 more
core   +1 more source

Immunotoxin Therapies for the Treatment of Epidermal Growth Factor Receptor-Dependent Cancers

open access: yesToxins, 2016
Many epithelial cancers rely on enhanced expression of the epidermal growth factor receptor (EGFR) to drive proliferation and survival pathways. Development of therapeutics to target EGFR signaling has been of high importance, and multiple examples have ...
Nathan Simon, David FitzGerald
doaj   +1 more source

In vitro cytotoxicity (IC50 ng/ml) of ABT-737, ABT-263, or ABT-199 in combination with 9.2.27-PE38KDEL immunotoxin.

open access: yes, 2019
In vitro cytotoxicity (IC50 ng/ml) of ABT-737, ABT-263, or ABT-199 in combination with 9.2.27-PE38KDEL immunotoxin.
Mikhail Dobrikov (3067083)   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy